NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma

BACKGROUND: Radiotherapy is the first-line regimen for treating oral squamous cell carcinoma (OSCC) in current clinics. However, the development of therapeutic resistance impacts the anticancer efficacy of irradiation in a subpopulation of OSCC patients. As a result, discovering a valuable biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Tsu-Zong, Lin, Hui-Yu, Kuei, Chia-Hao, Lin, Che-Hsuan, Lee, Hsun-Hua, Lee, Hsin-Lun, Lu, Hsiao-Wei, Su, Chia-Yi, Chiu, Hui-Wen, Lin, Yuan-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993556/
https://www.ncbi.nlm.nih.gov/pubmed/36890567
http://dx.doi.org/10.1186/s12935-023-02883-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993556/
https://www.ncbi.nlm.nih.gov/pubmed/36890567
http://dx.doi.org/10.1186/s12935-023-02883-0

Ejemplares similares